648905-23-1 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
Explanation
The compound is derived from benzene, which is a six-carbon ring with alternating single and double bonds.
Explanation
The presence of a bromine atom in the compound provides unique reactivity and properties for chemical reactions.
Explanation
This functional group is attached to the benzene ring and contributes to the compound's unique properties.
Explanation
The compound is a solid at room temperature and does not have any color.
Explanation
The molecular weight is the sum of the atomic weights of all the atoms in the molecule.
Explanation
The compound is used as a reagent in various chemical reactions to synthesize other organic compounds.
Explanation
The compound is also used in the development of pharmaceuticals and drug candidates.
Explanation
The presence of these functional groups gives the compound specific reactivity and properties that make it valuable for chemical research and industry.
Benzene derivative
Contains a benzene ring
Bromine atom
Contains one bromine atom
Trifluoroethylsulfonyl group
Contains a CF3CH2SO2group
Colorless solid
Appears as a colorless solid
Molecular weight
279.09 g/mol
Organic synthesis
Used in organic synthesis
Medicinal chemistry
Used in medicinal chemistry
Unique properties
Due to bromine and trifluoroethylsulfonyl groups
Check Digit Verification of cas no
The CAS Registry Mumber 648905-23-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,8,9,0 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 648905-23:
(8*6)+(7*4)+(6*8)+(5*9)+(4*0)+(3*5)+(2*2)+(1*3)=191
191 % 10 = 1
So 648905-23-1 is a valid CAS Registry Number.
648905-23-1Relevant articles and documents
SELECTIVE ESTROGEN RECEPTOR MODULATORS CONTAINING A PHENYLSULFONYL GROUP
-
Page/Page column 40, (2008/06/13)
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.